In reply
- PMID: 35655351
- PMCID: PMC9229583
- DOI: 10.3238/arztebl.m2022.0049
In reply
Comment on
-
Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.Dtsch Arztebl Int. 2021 Aug 9;118(31-32):528-535. doi: 10.3238/arztebl.m2021.0157. Dtsch Arztebl Int. 2021. PMID: 33734081 Free PMC article. Review.
References
-
- Katsanos K, Spiliopoulos S, Saha P, et al. Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis. PLoS One. 2015;10 e0135692. - PMC - PubMed
-
- Aboyans V, Bauersachs R, Mazzolai L, et al. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J. 2021 ehab390. - PubMed
-
- Fox KAA, Anand SS, Aboyans V, et al. Xarelto plus acetylsalicylic acid: treatment patterns and outcomes in patients with atherosclerosis (XATOA): rationale and design of a prospective registry study to assess rivaroxaban 25 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both. Am Heart J. 2020;222:166–173. - PubMed
Publication types
LinkOut - more resources
Full Text Sources